Michael Enxing Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Enxing.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Enxing. Michael Enxing is VP of Sales in NEVRO CORP ($NVRO) and VP of Sales & Marketing in NEVRO CORP ($NVRO).
Latest Insider Trading Transactions of Michael Enxing
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 37,108 | |
| Apr 05 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 94.48 | 300 | 28,343 | 40,463 | 40.8 K to 40.5 K (-0.74 %) |
| Apr 05 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 93.29 | 1,200 | 111,947 | 40,763 | 42 K to 40.8 K (-2.86 %) |
| Apr 05 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 41,963 | 40.5 K to 42 K (+3.71 %) |
| Mar 08 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 38,608 | |
| Mar 08 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 92.85 | 100 | 9,285 | 40,463 | 40.6 K to 40.5 K (-0.25 %) |
| Mar 08 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 92.35 | 600 | 55,412 | 40,563 | 41.2 K to 40.6 K (-1.46 %) |
| Mar 08 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 90.90 | 800 | 72,723 | 41,163 | 42 K to 41.2 K (-1.91 %) |
| Mar 08 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 41,963 | 40.5 K to 42 K (+3.71 %) |
| Mar 08 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 90.99 | 37,000 | 3,366,593 | 40,463 | 77.5 K to 40.5 K (-47.76 %) |
| Feb 08 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 40,108 | |
| Feb 08 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 93.27 | 1,500 | 139,908 | 77,463 | 79 K to 77.5 K (-1.90 %) |
| Feb 08 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 78,963 | 77.5 K to 79 K (+1.94 %) |
| Jan 30 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 37,000 | 133,200 | 41,608 | |
| Jan 30 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 37,000 | 133,200 | 77,463 | 40.5 K to 77.5 K (+91.44 %) |
| Jan 05 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 78,608 | |
| Jan 05 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 76.97 | 400 | 30,787 | 40,463 | 40.9 K to 40.5 K (-0.98 %) |
| Jan 05 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 76.12 | 500 | 38,059 | 40,863 | 41.4 K to 40.9 K (-1.21 %) |
| Jan 05 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 74.96 | 600 | 44,978 | 41,363 | 42 K to 41.4 K (-1.43 %) |
| Jan 05 2017 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 41,963 | 40.5 K to 42 K (+3.71 %) |
| Dec 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 80,108 | |
| Dec 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 76.38 | 1,500 | 114,573 | 40,463 | 42 K to 40.5 K (-3.57 %) |
| Dec 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 41,963 | 40.5 K to 42 K (+3.71 %) |
| Nov 18 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | A | 87.62 | 10,000 | 876,200 | 10,000 | |
| Nov 18 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Grant | A | 0.00 | 2,500 | 0 | 40,463 | 38 K to 40.5 K (+6.59 %) |
| Nov 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 81,608 | |
| Nov 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 88.68 | 19 | 1,685 | 37,963 | 38 K to 38 K (-0.05 %) |
| Nov 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 87.93 | 550 | 48,362 | 37,982 | 38.5 K to 38 K (-1.43 %) |
| Nov 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 86.29 | 300 | 25,887 | 38,532 | 38.8 K to 38.5 K (-0.77 %) |
| Nov 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 85.34 | 365 | 31,149 | 38,832 | 39.2 K to 38.8 K (-0.93 %) |
| Nov 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 83.75 | 266 | 22,278 | 39,197 | 39.5 K to 39.2 K (-0.67 %) |
| Nov 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
| Oct 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 83,108 | |
| Oct 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 100.46 | 100 | 10,046 | 37,963 | 38.1 K to 38 K (-0.26 %) |
| Oct 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 100.01 | 600 | 60,003 | 38,063 | 38.7 K to 38.1 K (-1.55 %) |
| Oct 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 98.64 | 800 | 78,914 | 38,663 | 39.5 K to 38.7 K (-2.03 %) |
| Oct 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
| Sep 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 84,608 | |
| Sep 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 96.94 | 1,100 | 106,637 | 37,963 | 39.1 K to 38 K (-2.82 %) |
| Sep 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 95.93 | 400 | 38,370 | 39,063 | 39.5 K to 39.1 K (-1.01 %) |
| Sep 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
| Aug 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 86,108 | |
| Aug 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 82.06 | 1,500 | 123,094 | 37,963 | 39.5 K to 38 K (-3.80 %) |
| Aug 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
| Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 87,608 | |
| Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 87,608 | |
| Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 75.80 | 400 | 30,321 | 37,963 | 38.4 K to 38 K (-1.04 %) |
| Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 75.80 | 400 | 30,321 | 37,963 | 38.4 K to 38 K (-1.04 %) |
| Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 75.24 | 1,100 | 82,761 | 38,363 | 39.5 K to 38.4 K (-2.79 %) |
| Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 75.24 | 1,100 | 82,761 | 38,363 | 39.5 K to 38.4 K (-2.79 %) |
| Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
| Jul 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
| Jun 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Option Exercise | M | 3.60 | 1,500 | 5,400 | 89,108 | |
| Jun 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Sell | S | 73.29 | 1,500 | 109,942 | 37,963 | 39.5 K to 38 K (-3.80 %) |
| Jun 08 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales | Buy | M | 3.60 | 1,500 | 5,400 | 39,463 | 38 K to 39.5 K (+3.95 %) |
| May 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Option Exercise | M | 3.60 | 1,500 | 5,400 | 90,608 | |
| May 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Sell | S | 65.84 | 440 | 28,969 | 37,413 | 37.9 K to 37.4 K (-1.16 %) |
| May 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Sell | S | 64.74 | 1,060 | 68,627 | 37,853 | 38.9 K to 37.9 K (-2.72 %) |
| May 06 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Buy | M | 3.60 | 1,500 | 5,400 | 38,913 | 37.4 K to 38.9 K (+4.01 %) |
| Apr 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Option Exercise | M | 3.60 | 8,767 | 31,561 | 92,108 | |
| Apr 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Sell | S | 61.95 | 4,733 | 293,208 | 37,413 | 42.1 K to 37.4 K (-11.23 %) |
| Apr 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Sell | S | 61.16 | 4,034 | 246,725 | 42,146 | 46.2 K to 42.1 K (-8.74 %) |
| Apr 05 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Buy | M | 3.60 | 8,767 | 31,561 | 46,180 | 37.4 K to 46.2 K (+23.43 %) |
| Mar 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Option Exercise | M | 3.60 | 37,000 | 133,200 | 100,875 | |
| Mar 07 2016 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Buy | M | 3.60 | 37,000 | 133,200 | 37,413 | 413 to 37.4 K (+8,958.84 %) |
| Dec 03 2015 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Option Exercise | A | 63.23 | 13,300 | 840,959 | 13,300 | |
| Nov 07 2014 | NVRO | NEVRO CORP | Enxing Michael | VP of Sales & Marke ... | Option Exercise | A | 18.00 | 28,257 | 508,626 | 28,257 |
Page: 1